1
|
Gerard E, Quindroit P, Lemaitre M, Robert L, Gautier S, Decaudin B, Vambergue A, Beuscart JB. Defining explicit definitions of potentially inappropriate prescriptions for antidiabetic drugs in patients with type 2 diabetes: A systematic review. PLoS One 2022; 17:e0274256. [PMID: 36094919 PMCID: PMC9467327 DOI: 10.1371/journal.pone.0274256] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2022] [Accepted: 08/25/2022] [Indexed: 11/18/2022] Open
Abstract
Introduction Potentially inappropriate prescriptions (PIPs) of antidiabetic drugs (ADs) (PIPADs) to patients with type 2 diabetes mellitus (T2DM) have been reported in some studies. The detection of PIPs in electronic databases requires the development of explicit definitions. This approach is widely used in geriatrics but has not been extended to PIPADs in diabetes mellitus. The objective of the present literature review was to identify all explicit definitions of PIPADs in patients with T2DM. Materials and methods We performed a systematic review of the literature listed on Medline (via PubMed), Scopus, Web of Science, and, Embase between 2010 and 2021. The query included a combination of three concepts ("T2DM" AND "PIPs" AND "ADs") and featured a total of 86 keywords. Two independent reviewers selected publications, extracted explicit definitions of PIPADs, and then classified the definitions by therapeutic class and organ class. Results Of the 4,093 screened publications, 39 were included. In all, 171 mentions of PIPADs (corresponding to 56 unique explicit definitions) were identified. More than 50% of the definitions were related to either metformin (34%) or sulfonylureas (29%). More than 75% of the definitions were related to either abnormal renal function (56%) or age (22%). In addition, 20% (n = 35) mentions stated that biguanides were inappropriate in patients with renal dysfunction and 17.5% (n = 30) stated that sulfonylureas were inappropriate above a certain age. The definitions of PIPADs were heterogeneous and had various degrees of precision. Conclusion Our results showed that researchers focused primarily on the at-risk situations related to biguanide prescriptions in patients with renal dysfunction and the prescription of sulfonylureas to older people. Our systematic review of the literature revealed a lack of consensus on explicit definitions of PIPADs, which were heterogeneous and limited (in most cases) to a small number of drugs and clinical situations.
Collapse
Affiliation(s)
- Erwin Gerard
- Univ. Lille, CHU Lille, ULR 2694 - METRICS: Évaluation des Technologies de Santé et des Pratiques Médicales, Lille, France
- CHU Lille, Institut de Pharmacie, Lille, France
- * E-mail:
| | - Paul Quindroit
- Univ. Lille, CHU Lille, ULR 2694 - METRICS: Évaluation des Technologies de Santé et des Pratiques Médicales, Lille, France
| | - Madleen Lemaitre
- CHU Lille, Department of Diabetology, Endocrinology, Metabolism and Nutrition, Lille University Hospital, Lille, France
- University of Lille, Lille, France
| | - Laurine Robert
- Univ. Lille, CHU Lille, ULR 2694 - METRICS: Évaluation des Technologies de Santé et des Pratiques Médicales, Lille, France
- CHU Lille, Institut de Pharmacie, Lille, France
| | - Sophie Gautier
- CHU de Lille, Centre Régional de Pharmacovigilance, Lille, France
| | - Bertrand Decaudin
- CHU Lille, Institut de Pharmacie, Lille, France
- Univ. Lille, CHU Lille, ULR 7365 - GRITA: Groupe de Recherche sur les Formes Injectables et les Technologies Associées, Lille, France
| | - Anne Vambergue
- CHU Lille, Department of Diabetology, Endocrinology, Metabolism and Nutrition, Lille University Hospital, Lille, France
- European Genomic Institute for Diabetes, University School of Medicine, Lille, France
| | - Jean-Baptiste Beuscart
- Univ. Lille, CHU Lille, ULR 2694 - METRICS: Évaluation des Technologies de Santé et des Pratiques Médicales, Lille, France
| |
Collapse
|
2
|
Aloy B, Janus N, Isnard-Bagnis C, Deray G, Launay-Vacher V. [Renal toxicity of anticancer drugs]. Nephrol Ther 2021; 17:553-563. [PMID: 34802974 DOI: 10.1016/j.nephro.2021.09.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
The renal toxicity of anticancer drugs is a clinical challenge because of the intrinsic toxicity of some anticancer drugs and because the cancer itself. Indeed, cancer patients are exposed to all types of renal disorders (obstructive, functional, organic because of radiotherapy, paraneoplastic glomerulopathy, thrombotic microangiopathy…). The therapeutic index of anticancer drugs is often narrow and the doses used for optimal efficacy are high. Improving safety requires a better dose adjustment, which depends on the correct evaluation of the renal function. Prevention remains important as the mortality associated with acute renal failure is very high.
Collapse
Affiliation(s)
- Blandine Aloy
- Service de néphrologie, groupe hospitalier Pitié-Salpêtrière-Charles-Foix, 83, boulevard de l'Hôpital, 75013 Paris, France; Service information conseil adaptation rénale (Icar), cour des consultations porte 12, hôpital Pitié-Salpêtrière, 83, boulevard de l'Hôpital, 75013 Paris, France.
| | - Nicolas Janus
- Service de néphrologie, groupe hospitalier Pitié-Salpêtrière-Charles-Foix, 83, boulevard de l'Hôpital, 75013 Paris, France; Service information conseil adaptation rénale (Icar), cour des consultations porte 12, hôpital Pitié-Salpêtrière, 83, boulevard de l'Hôpital, 75013 Paris, France; Cancer and the Kidney International Network, boulevard du Souverain, 280, 1160 Bruxelles, Belgique
| | - Corine Isnard-Bagnis
- Service de néphrologie, groupe hospitalier Pitié-Salpêtrière-Charles-Foix, 83, boulevard de l'Hôpital, 75013 Paris, France; Campus Pierre-et-Marie-Curie, Sorbonne Université, 4, place Jussieu, 75005 Paris, France
| | - Gilbert Deray
- Service de néphrologie, groupe hospitalier Pitié-Salpêtrière-Charles-Foix, 83, boulevard de l'Hôpital, 75013 Paris, France; Service information conseil adaptation rénale (Icar), cour des consultations porte 12, hôpital Pitié-Salpêtrière, 83, boulevard de l'Hôpital, 75013 Paris, France; Cancer and the Kidney International Network, boulevard du Souverain, 280, 1160 Bruxelles, Belgique; Campus Pierre-et-Marie-Curie, Sorbonne Université, 4, place Jussieu, 75005 Paris, France
| | - Vincent Launay-Vacher
- Service de néphrologie, groupe hospitalier Pitié-Salpêtrière-Charles-Foix, 83, boulevard de l'Hôpital, 75013 Paris, France; Service information conseil adaptation rénale (Icar), cour des consultations porte 12, hôpital Pitié-Salpêtrière, 83, boulevard de l'Hôpital, 75013 Paris, France; Cancer and the Kidney International Network, boulevard du Souverain, 280, 1160 Bruxelles, Belgique
| |
Collapse
|
3
|
Antibiotics and chronic kidney disease: Dose adjustment update for infectious disease clinical practice. Med Mal Infect 2019; 50:323-331. [PMID: 31326299 DOI: 10.1016/j.medmal.2019.06.010] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2018] [Revised: 04/10/2018] [Accepted: 06/24/2019] [Indexed: 12/16/2022]
Abstract
Antibiotic prescription in chronic kidney disease patients poses a twofold problem. The appropriate use of antibacterial agents is essential to ensure efficacy and to prevent the emergence of resistance, and dosages should be adapted to the renal function to prevent adverse effects. SiteGPR is a French website for health professionals to help with prescriptions to chronic kidney disease patients. A working group of infectious disease specialists and nephrology pharmacists reviewed the indications, dosing regimens, administration modalities, and dose adjustments of antibiotics marketed in France for patients with renal failure. Data available on the SiteGPR website and detailed in the present article aims to provide an evidence-based update of infectious disease recommendations to health professionals managing patients with chronic kidney disease.
Collapse
|
4
|
Keller N, Ruppert M, Fourtage M, Hannedouche T. Médicaments du système cardiovasculaire et fonction rénale : les pièges de l’adaptation rénale. Nephrol Ther 2019; 15:97-103. [DOI: 10.1016/j.nephro.2018.11.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2018] [Revised: 10/28/2018] [Accepted: 11/04/2018] [Indexed: 10/27/2022]
|
5
|
Laville SM, Metzger M, Stengel B, Jacquelinet C, Combe C, Fouque D, Laville M, Frimat L, Ayav C, Speyer E, Robinson BM, Massy ZA, Liabeuf S. Evaluation of the adequacy of drug prescriptions in patients with chronic kidney disease: results from the CKD-REIN cohort. Br J Clin Pharmacol 2018; 84:2811-2823. [PMID: 30110711 PMCID: PMC6255993 DOI: 10.1111/bcp.13738] [Citation(s) in RCA: 63] [Impact Index Per Article: 10.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2018] [Revised: 07/31/2018] [Accepted: 08/05/2018] [Indexed: 02/06/2023] Open
Abstract
AIMS Drug prescription is difficult to manage in patients with chronic kidney disease (CKD). We assessed the prevalence and determinants of inappropriate drug prescriptions (whether contraindications or inappropriately high doses) with regard to kidney function in patients with CKD under nephrology care. We also assessed the impact of the equation used to estimate GFR on the prevalence estimates. METHODS The CKD-REIN cohort includes 3033 outpatients with CKD (eGFR between 15 and 60 ml min-1 1.73 m-2 ). We examined the daily doses of pharmacological agents prescribed at study entry. Inappropriate prescription was defined as the reported prescription of either a contraindicated drug or an indicated drug at an inappropriately high dose level with regard to the patient's GFR, as estimated with the CKD-EPI equation, the de-indexed CKD-EPI equation, or the Cockcroft-Gault (CG) equation. Multivariate logistic regression was used to assess the determinants of inappropriate prescription risk. RESULTS At baseline, patients' median [interquartile range] number of drugs prescribed per patient was 8 [5-10]. Half of the patients had been prescribed at least one inappropriate drug. Anti-gout, cardiovascular agents and antidiabetic agents accounted for most of the inappropriate prescriptions. The percentage of inappropriate prescriptions varied from one GFR equation to another: 52% when using the CKD-EPI equation, 47% when using the de-indexed CKD-EPI equation and 41% with the CG equation. A multiple logistic regression analysis showed significantly higher odds ratios [95% confidence interval] for inappropriate prescriptions in male patients (1.28 [1.07; 1.53]), patients with diabetes (1.34 [1.06; 1.70]), those with a high BMI (1.58 [1.25; 1.99]), and those with a low GFR (10.2 [6.02; 17.3]). The risk of having at least one inappropriate prescription increased with the number of drugs per patient (P for trend < 0.0001) and therefore the odds ratio was 5.88 [4.17; 8.28] for those who received at least 11 prescribed medications compared to those who received fewer than 5. CONCLUSION Our results emphasize the complexity of drug management for CKD patients, for whom inappropriate prescription appears to be common.
Collapse
Affiliation(s)
- Solène M. Laville
- CESP Centre for Research in Epidemiology and Population HealthUniv Paris‐Saclay, Univ Paris Sud, UVSQ, UMRS 1018F‐94807VillejuifFrance
| | - Marie Metzger
- CESP Centre for Research in Epidemiology and Population HealthUniv Paris‐Saclay, Univ Paris Sud, UVSQ, UMRS 1018F‐94807VillejuifFrance
| | - Bénédicte Stengel
- CESP Centre for Research in Epidemiology and Population HealthUniv Paris‐Saclay, Univ Paris Sud, UVSQ, UMRS 1018F‐94807VillejuifFrance
| | - Christian Jacquelinet
- CESP Centre for Research in Epidemiology and Population HealthUniv Paris‐Saclay, Univ Paris Sud, UVSQ, UMRS 1018F‐94807VillejuifFrance
- Agence de la BiomédecineSaint‐DenisFrance
| | - Christian Combe
- Service de Néphrologie Transplantation Dialyse AphérèseCentre Hospitalier Universitaire de BordeauxBordeauxFrance
- INSERM, U1026Univ Bordeaux SegalenBordeauxFrance
| | - Denis Fouque
- Department of NephrologyCentre Hospitalier Lyon Sud, Univ Lyon, UCBL, CarmenF‐69495Pierre‐BéniteFrance
| | - Maurice Laville
- Department of NephrologyCentre Hospitalier Lyon Sud, Univ Lyon, UCBL, CarmenF‐69495Pierre‐BéniteFrance
| | - Luc Frimat
- Clinical EpidemiologyInserm CIC‐EC, CHU de NancyVandoeuvre‐lès‐NancyFrance
- Nephrology DepartmentCHU de NancyVandoeuvre‐lès‐NancyFrance
| | - Carole Ayav
- Clinical EpidemiologyInserm CIC‐EC, CHU de NancyVandoeuvre‐lès‐NancyFrance
| | - Elodie Speyer
- CESP Centre for Research in Epidemiology and Population HealthUniv Paris‐Saclay, Univ Paris Sud, UVSQ, UMRS 1018F‐94807VillejuifFrance
| | | | - Ziad A. Massy
- CESP Centre for Research in Epidemiology and Population HealthUniv Paris‐Saclay, Univ Paris Sud, UVSQ, UMRS 1018F‐94807VillejuifFrance
- Nephrology DepartmentCHU Ambroise PareBoulogneFrance
| | - Sophie Liabeuf
- Pharmacology departmentAmiens University HospitalAmiensFrance
- INSERM U1088Jules Vernes UniversityAmiensFrance
| | | |
Collapse
|
6
|
Estimation et mesure du débit de filtration glomérulaire : en quête de précision. Nephrol Ther 2018; 14 Suppl 1:S59-S66. [DOI: 10.1016/j.nephro.2018.02.005] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2017] [Accepted: 02/01/2018] [Indexed: 11/22/2022]
|
7
|
Aloy B, Desplanques PY, Gurgel S, Deray G, Launay-Vacher V. Médicaments et insuffisance rénale. ACTUALITES PHARMACEUTIQUES 2018. [DOI: 10.1016/j.actpha.2017.11.007] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
8
|
Cartet-Farnier E, Goutelle-Audibert L, Maire P, De la Gastine B, Goutelle S. Implications of using the MDRD or CKD-EPI equation instead of the Cockcroft-Gault equation for estimating renal function and drug dosage adjustment in elderly patients. Fundam Clin Pharmacol 2016; 31:110-119. [PMID: 27599753 DOI: 10.1111/fcp.12241] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2016] [Revised: 08/30/2016] [Accepted: 09/02/2016] [Indexed: 11/30/2022]
Abstract
The objectives of this study were to compare the estimations of renal function obtained with six equations, including the Cockcroft-Gault (CG), Modification of Diet in Renal Disease (MDRD), and Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations and to evaluate the implication of using other equations for drug dosing in elderly patients in place of CG. An observational prospective study was conducted over 6 months in two geriatric hospitals with inclusions of all hospitalized inpatients. A list of 36 drugs for which recommendations of dosage adjustment for renal function were mentioned in the manufacturer dosing guidelines was used to compare the implications of using the various equations for drug dosing. A total of 249 patients with a mean age of 83.6 years were included. Mean estimates of renal function from the CG, MDRD, and CKD-EPI equations were 51.3 ± 23.5 mL/min, 72.2 ± 35.2, and 64.3 ± 22.5 mL/min/1.73 m2 , respectively (P < 0.001). Twenty percent of patients had at least one drug for which the dose was not appropriately adjusted to renal function. The use of the MDRD and CKD-EPI equations in place of the CG equation was associated with dosage discrepancy in 20-25% of patients and 15% of drug orders, resulting in potential overdosage in 95% of cases. Use of MDRD or CKD-EPI equations results in higher estimates of renal function and may have important implications for drug dosing decision and drug safety in elderly patients. The best way is to directly measure the drug effect or its concentration when it is possible to do so.
Collapse
Affiliation(s)
- Elodie Cartet-Farnier
- Groupement Hospitalier de Gériatrie, Service pharmaceutique, Hospices Civils de Lyon, 136 rue du Commandant Charcot, 69005, Lyon, France
| | - Laetitia Goutelle-Audibert
- Service pharmaceutique, Centre Hospitalier de Saint Laurent de Chamousset, Le Grand Jardin, Chemin du Grand Jardin, 69930, Saint-Laurent de Chamousset, France
| | - Pascal Maire
- Groupement Hospitalier de Gériatrie, Service pharmaceutique, Hospices Civils de Lyon, 136 rue du Commandant Charcot, 69005, Lyon, France.,UMR CNRS 5558, Laboratoire de Biométrie et Biologie Evolutive, Université Lyon 1, 43 bd du 11 novembre 1918, 69622, Villeurbanne, France
| | - Blandine De la Gastine
- Groupement Hospitalier de Gériatrie, Médecine Gériatrique, Hospices Civils de Lyon, Lyon, France
| | - Sylvain Goutelle
- Groupement Hospitalier de Gériatrie, Service pharmaceutique, Hospices Civils de Lyon, 136 rue du Commandant Charcot, 69005, Lyon, France.,UMR CNRS 5558, Laboratoire de Biométrie et Biologie Evolutive, Université Lyon 1, 43 bd du 11 novembre 1918, 69622, Villeurbanne, France.,Faculté de Pharmacie de Lyon, Université Lyon 1, 8 avenue Rockefeller, 69373, Lyon Cedex 08, France
| |
Collapse
|